Sentinel lymphadenectomy in the management of primary cutaneous malignant melanoma: An update

W. L. White, Brian W. Loggie

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

The management of lymph nodes in melanoma patients who have no clinical evidence of nodal disease has changed dramatically with the development of selective lymph node biopsy. This procedure localizes the node in a regional basin most likely to contain a metastasis (the sentinel node) and averts the morbidity of unnecessary elective node dissection. This update reviews the rationale for this procedure and describes the methodology used by the surgeon and the pathologist. A progress report highlights the promise and limitation of this procedure. Sentinel node biopsy is currently the standard for staging select groups of melanoma patients, but the field is rapidly evolving and may eventually be surpassed by even newer molecular diagnostic techniques.

Original languageEnglish
Pages (from-to)645-655
Number of pages11
JournalDermatologic Clinics
Volume17
Issue number3
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Lymph Node Excision
Melanoma
Molecular Diagnostic Techniques
Lymph Nodes
Biopsy
Dissection
Neoplasm Metastasis
Morbidity
cyhalothrin
Cutaneous Malignant Melanoma

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Sentinel lymphadenectomy in the management of primary cutaneous malignant melanoma : An update. / White, W. L.; Loggie, Brian W.

In: Dermatologic Clinics, Vol. 17, No. 3, 1999, p. 645-655.

Research output: Contribution to journalReview article

@article{2b0b007e120345c496ad3c6976e900ba,
title = "Sentinel lymphadenectomy in the management of primary cutaneous malignant melanoma: An update",
abstract = "The management of lymph nodes in melanoma patients who have no clinical evidence of nodal disease has changed dramatically with the development of selective lymph node biopsy. This procedure localizes the node in a regional basin most likely to contain a metastasis (the sentinel node) and averts the morbidity of unnecessary elective node dissection. This update reviews the rationale for this procedure and describes the methodology used by the surgeon and the pathologist. A progress report highlights the promise and limitation of this procedure. Sentinel node biopsy is currently the standard for staging select groups of melanoma patients, but the field is rapidly evolving and may eventually be surpassed by even newer molecular diagnostic techniques.",
author = "White, {W. L.} and Loggie, {Brian W.}",
year = "1999",
doi = "10.1016/S0733-8635(05)70113-3",
language = "English",
volume = "17",
pages = "645--655",
journal = "Dermatologic Clinics",
issn = "0733-8635",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Sentinel lymphadenectomy in the management of primary cutaneous malignant melanoma

T2 - An update

AU - White, W. L.

AU - Loggie, Brian W.

PY - 1999

Y1 - 1999

N2 - The management of lymph nodes in melanoma patients who have no clinical evidence of nodal disease has changed dramatically with the development of selective lymph node biopsy. This procedure localizes the node in a regional basin most likely to contain a metastasis (the sentinel node) and averts the morbidity of unnecessary elective node dissection. This update reviews the rationale for this procedure and describes the methodology used by the surgeon and the pathologist. A progress report highlights the promise and limitation of this procedure. Sentinel node biopsy is currently the standard for staging select groups of melanoma patients, but the field is rapidly evolving and may eventually be surpassed by even newer molecular diagnostic techniques.

AB - The management of lymph nodes in melanoma patients who have no clinical evidence of nodal disease has changed dramatically with the development of selective lymph node biopsy. This procedure localizes the node in a regional basin most likely to contain a metastasis (the sentinel node) and averts the morbidity of unnecessary elective node dissection. This update reviews the rationale for this procedure and describes the methodology used by the surgeon and the pathologist. A progress report highlights the promise and limitation of this procedure. Sentinel node biopsy is currently the standard for staging select groups of melanoma patients, but the field is rapidly evolving and may eventually be surpassed by even newer molecular diagnostic techniques.

UR - http://www.scopus.com/inward/record.url?scp=0033051103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033051103&partnerID=8YFLogxK

U2 - 10.1016/S0733-8635(05)70113-3

DO - 10.1016/S0733-8635(05)70113-3

M3 - Review article

C2 - 10410864

AN - SCOPUS:0033051103

VL - 17

SP - 645

EP - 655

JO - Dermatologic Clinics

JF - Dermatologic Clinics

SN - 0733-8635

IS - 3

ER -